15 Scopus citations


The purpose of this study was to analyze the prognostic significance of early lymphocyte recovery after autologous SCT (ASCT) in the setting of routine post transplant administration of GM-CSF in patients with non-Hodgkin's lymphoma (NHL). This is a single institution retrospective comparative outcome analysis in a cohort of 268 relapsed chemosensitive NHL patients divided into two groups (early and late lymphocyte recovery) based on absolute lymphocyte counts (ALC) obtained on post transplant day + 15 (ALC≥500, n = 151 (56%) and ALC<500, n = 117 (44%)). Patient's characteristics were well-balanced between the two groups with regard to age, sex, preparative regimen, prior therapy, time from diagnosis to transplant and number of CD34 + cells infused. Post transplant complications were comparable in the two groups. Late lymphocyte recovery (ALC <500 on day + 15) was independently associated with a delay in platelet recovery (29 vs 21 days, P = 0.0003) in patients who have not received pre-transplant rituximab. With a median follow-up of 22 months, no associations between early lymphocyte recovery and improvement of disease-free and overall survival were observed for either low- or intermediate-grade NHL. In conclusion, in this large single-centered retrospective analysis, where patients received routine post transplant GM-CSF, early lymphocyte recovery was not associated with favorable outcomes.

Original languageEnglish
Pages (from-to)671-675
Number of pages5
JournalBone Marrow Transplantation
Issue number7
StatePublished - Oct 2007


Dive into the research topics of 'Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Cite this